ロード中...
TG4010: A therapeutic vaccine against MUC1 expressing tumors
TG4010 is a therapeutic cancer vaccine based on a viral vector, a modified vaccinia of Ankara (MVA), expressing MUC1 as well as interleukine 2. Today the clinical development is focused on advanced non-small cell lung cancer in combination with first line chemotherapy. Potential biomarkers predictiv...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Landes Bioscience
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3429597/ https://ncbi.nlm.nih.gov/pubmed/22934285 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.19863 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|